Gabelli & CO Investment Advisers, Inc. Vigil Neuroscience, Inc. Transaction History
Gabelli & CO Investment Advisers, Inc.
- $584 Million
- Q2 2025
A detailed history of Gabelli & CO Investment Advisers, Inc. transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Gabelli & CO Investment Advisers, Inc. holds 864,950 shares of VIGL stock, worth $6.96 Million. This represents 1.18% of its overall portfolio holdings.
Number of Shares
864,950Holding current value
$6.96 Million% of portfolio
1.18%Shares
1 transactions
Others Institutions Holding VIGL
# of Institutions
80Shares Held
38MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$47 Million10.21% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA4.61MShares$37.1 Million5.55% of portfolio
-
Northpond Ventures, LLC4.21MShares$33.9 Million51.65% of portfolio
-
Glazer Capital, LLC New York, NY3.01MShares$24.2 Million0.86% of portfolio
-
Oddo Bhf Asset Management Sas Paris, I02.3MShares$18.5 Million0.72% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $228M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...